{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:28:08Z","timestamp":1788546488785,"version":"build-2803163510"},"reference-count":40,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["JP17K16265"],"award-info":[{"award-number":["JP17K16265"]}]},{"name":"JSPS KAKENHI","award":["JP20K17554"],"award-info":[{"award-number":["JP20K17554"]}]},{"name":"JSPS KAKENHI","award":["19ck0106332h0003"],"award-info":[{"award-number":["19ck0106332h0003"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency Medical Research","doi-asserted-by":"publisher","award":["JP17K16265"],"award-info":[{"award-number":["JP17K16265"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency Medical Research","doi-asserted-by":"publisher","award":["JP20K17554"],"award-info":[{"award-number":["JP20K17554"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency Medical Research","doi-asserted-by":"publisher","award":["19ck0106332h0003"],"award-info":[{"award-number":["19ck0106332h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: The membrane protein a disintegrin and metalloproteases (ADAMs) are highly expressed in various human carcinomas and play an important role in cancer characteristics. And among these, ADAM32 is highly expressed in hepatoblastoma (HBL) and plays an important role in oncogenic properties. However, the regulatory mechanism has not been determined. Recently, it has been reported that some ADAMs are regulated by HIF, which is an important transcription factor in response to hypoxia. Therefore, we decided to study the regulatory mechanisms of ADAM32 under hypoxic conditions by using HBL, breast, and lung cancer cell lines. Methods\/Results: When these cells were exposed to 1% O2 (hypoxia), it was found that the levels of ADAM32 increased at 48 h in HepG2, MCF7, and MDA-MB-231 but not in HUH-6 or lung cancer lines. However, the promoter activity of the ADAM32 gene in HepG2 remained unchanged under hypoxic conditions, suggesting that the level of ADAM32 in HBL is regulated by factors other than the promoter activity. From the microarray data, we found that the level of IGF2BP2, which is an m6A-related molecule, correlated with that of ADAM32, and these levels were decreased by HIF1A knockdown. And IGF2BP2 knockdown decreased the expression of ADAM32 and attenuated the increased expression of ADAM32 under hypoxic conditions. Conclusions: This study demonstrated that the oncogenic gene ADAM32 is regulated by IGF2BP2 and that IGF2BP2 could be a molecular target for HBL anticancer therapy.<\/jats:p>","DOI":"10.3390\/cancers17111772","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T23:49:27Z","timestamp":1748216967000},"page":"1772","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ADAM32 Oncogene in Hepatoblastoma Is Regulated by IGF2BP2"],"prefix":"10.3390","volume":"17","author":[{"given":"Takahiro","family":"Fukazawa","sequence":"first","affiliation":[{"name":"Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan"},{"name":"Division of Medical Research Support, Advanced Research Support Center, Ehime University, Toon 791-0295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4912-4197","authenticated-orcid":false,"given":"Keiji","family":"Tanimoto","sequence":"additional","affiliation":[{"name":"Department of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kojima","sequence":"additional","affiliation":[{"name":"Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan"},{"name":"Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2289-9320","authenticated-orcid":false,"given":"Masami","family":"Kanawa","sequence":"additional","affiliation":[{"name":"Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6237-214X","authenticated-orcid":false,"given":"Nobuyuki","family":"Hirohashi","sequence":"additional","affiliation":[{"name":"Department of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9179-5037","authenticated-orcid":false,"given":"Eiso","family":"Hiyama","sequence":"additional","affiliation":[{"name":"Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"ref_1","first-page":"293","article-title":"Pediatric Hepatoblastoma: Diagnosis and Treatment","volume":"3","author":"Hiyama","year":"2014","journal-title":"Transl. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.12688\/f1000research.12239.1","article-title":"Hepatoblastoma: Current Understanding, Recent Advances, and Controversies","volume":"7","author":"Czauderna","year":"2018","journal-title":"F1000Research"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jpedsurg.2016.09.038","article-title":"Resectability and Tumor Response after Preoperative Chemotherapy in Hepatoblastoma Treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 Protocol","volume":"51","author":"Hiyama","year":"2016","journal-title":"J. Pediatr. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e27383","DOI":"10.1002\/pbc.27383","article-title":"Surgical Treatment Strategy for Advanced Hepatoblastoma: Resection versus Transplantation","volume":"65","author":"Uchida","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1442-200x.1999.01022.x","article-title":"Prenatal and postnatal histories of very low birthweight infants who developed hepatoblastoma","volume":"41","author":"Maruyama","year":"1999","journal-title":"Pediatr. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1349-7006.2007.00434.x","article-title":"ADAMs in Cancer Cell Proliferation and Progression","volume":"98","author":"Mochizuki","year":"2007","journal-title":"Cancer Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/1078-0432.CCR-08-1585","article-title":"Role of ADAMs in Cancer Formation and Progression","volume":"15","author":"Duffy","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/15384047.2016.1177684","article-title":"The ADAMs Family of Proteases as Targets for the Treatment of Cancer","volume":"17","author":"Mullooly","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Fukazawa, T., Tanimoto, K., Yamaoka, E., Kojima, M., Kanawa, M., Hirohashi, N., and Hiyama, E. (2022). Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy. Cancers, 14.","DOI":"10.3390\/cancers14194732"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for Cancer Therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biotechadv.2016.04.005","article-title":"Hypoxic Tumor Microenvironment: Opportunities to Develop Targeted Therapies","volume":"34","author":"Patel","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/jcp.25859","article-title":"Modulating Tumor Hypoxia by Nanomedicine for Effective Cancer Therapy","volume":"233","author":"Ahmadi","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21603","DOI":"10.1074\/jbc.M115.651604","article-title":"High Glucose Up-Regulates ADAM17 through HIF-1\u03b1 in Mesangial Cells","volume":"290","author":"Li","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16325","DOI":"10.1074\/jbc.M109.001313","article-title":"ADAMTS1 Is a Unique Hypoxic Early Response Gene Expressed by Endothelial Cells","volume":"284","author":"Hatipoglu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1242\/jeb.201.8.1153","article-title":"Oxygen Sensing, Hypoxia-Inducible Factor-1 and the Regulation of Mammalian Gene Expression","volume":"201","author":"Ratcliffe","year":"1998","journal-title":"J. Exp. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s00018-003-2370-y","article-title":"The Hypoxia-Inducible Factors: Key Transcriptional Regulators of Hypoxic Responses","volume":"60","author":"Bracken","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41576-023-00645-2","article-title":"RNA Modifications in Physiology and Disease: Towards Clinical Applications","volume":"25","author":"Delaunay","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","article-title":"The roles and implications of RNA m6A modification in cancer","volume":"20","author":"Deng","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"W124","DOI":"10.1093\/nar\/gkh442","article-title":"SiDirect: Highly Effective, Target-Specific SiRNA Design Software for Mammalian RNA Interference","volume":"32","author":"Naito","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Naito, Y., Yoshimura, J., Morishita, S., and Ui-Tei, K. (2009). SiDirect 2.0: Updated Software for Designing Functional SiRNA with Reduced Seed-Dependent off-Target Effect. BMC Bioinform., 10.","DOI":"10.1186\/1471-2105-10-392"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","article-title":"Hep G2 Is a Hepatoblastoma-Derived Cell Line","volume":"40","author":"Cheung","year":"2009","journal-title":"Hum. Pathol."},{"key":"ref_22","first-page":"1","article-title":"Establishment of a Cell Line and Its Clonal Sublines from a Patient with Hepatoblastoma","volume":"67","author":"Doi","year":"1976","journal-title":"Gan"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","article-title":"Mechanism of Regulation of the Hypoxia-Inducible Factor-1 Alpha by the von Hippel-Lindau Tumor Suppressor Protein","volume":"19","author":"Tanimoto","year":"2000","journal-title":"EMBO J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbrc.2013.10.083","article-title":"The Kr\u00fcppel-like Zinc Finger Transcription Factor, GLI-Similar 1, Is Regulated by Hypoxia-Inducible Factors via Non-Canonical Mechanisms","volume":"441","author":"Khalesi","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/nar\/gkw104","article-title":"SRAMP: Prediction of Mammalian N6-Methyladenosine (M6A) Sites Based on Sequence-Derived Features","volume":"44","author":"Zhou","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15995","DOI":"10.1002\/anie.201807942","article-title":"An Elongation- and Ligation-Based QPCR Amplification Method for the Radiolabeling-Free Detection of Locus-Specific N6 -Methyladenosine Modification","volume":"57","author":"Xiao","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/anie.202007266","article-title":"LEAD-M6 A-Seq for Locus-Specific Detection of N6 -Methyladenosine and Quantification of Differential Methylation","volume":"60","author":"Wang","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Xu, J., Liu, Y., Liu, J., Xu, T., Cheng, G., Shou, Y., Tong, J., Liu, L., Zhou, L., and Xiao, W. (2020). The Identification of Critical m6A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.602485"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1073\/pnas.0907705107","article-title":"Negative feedback control of Hif-1 through REDD1-regulated ROS suppresses tumorigenesis","volume":"107","author":"Horak","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA Modifications in Gene Expression Regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic Transcriptomic M6A Decoration: Writers, Erasers, Readers and Functions in RNA Metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-Transcriptional Gene Regulation by MRNA Modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1261\/rna.061044.117","article-title":"N6-Methyladenosine Is Required for the Hypoxic Stabilization of Specific MRNAs","volume":"23","author":"Fry","year":"2017","journal-title":"RNA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbagrm.2018.09.008","article-title":"The M6A-methylase Complex and MRNA Export","volume":"1862","author":"Lesbirel","year":"2019","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ejca.2012.12.003","article-title":"An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3","volume":"49","author":"Ramachandran","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/acschembio.1c00833","article-title":"First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2\/IMP2 for Cancer Therapy","volume":"17","author":"Dahlem","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41375-022-01651-9","article-title":"Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia","volume":"36","author":"Feng","year":"2022","journal-title":"Leukemia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Li, D., Hu, S., Ye, J., Zhai, C., Liu, J., Wang, Z., Zhou, X., Chen, L., and Zhou, F. (2024). The Emerging Role of IGF2BP2 in Cancer Therapy Resistance: From Molecular Mechanism to Future Potential. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212150"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4217259","DOI":"10.1155\/2018\/4217259","article-title":"The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells","volume":"2018","author":"Cao","year":"2018","journal-title":"Stem Cells Int."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/11\/1772\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:40:15Z","timestamp":1760031615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/11\/1772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["cancers17111772"],"URL":"https:\/\/doi.org\/10.3390\/cancers17111772","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]}}}